VahatiCor Begins United States SERRA-I Early Feasibility Study of A-Flux Reducer System for Microvascular Dysfunction

Marketplace

Please login to access the CRTOnline.

VahatiCor Begins United States SERRA-I Early Feasibility Study of A-Flux Reducer System for Microvascular Dysfunction

VahatiCor, Inc., a developer of interventional therapies for coronary microvascular dysfunction (CMD), announced the enrollment of the first United States patient in its SERRA-I early feasibility study.

DMV (July 2026) Feasibility and Challenges of the UNICORN Technique in Native Aortic Valve TAVI

Pericardiocentesis

Older, Symptomatic Patients With Mild Hypertrophic Cardiomyopathy More Likely to Develop MACE: SHaRe Registry

Pulsed Field Ablation for AF Shows Low Complication Rate, No Esophageal or Persistent Phrenic Injury: Registry Study

Optimizing Femoral Closure with ANGIO-SEAL® VIP Vascular Closure Device

King and I | S7 E1 | Politics of Federal Funding Cuts

Transapical Bioprosthetic Leaflets Removal to Prevent LV Outflow Tract Obstruction During Mitral ViV

DMV (July 2026) When Three Collide: Left Main, Valve, and Ventricle

King and I | S6 E10 | Should we keep the NCD for TAVR?

Double LLAMACORN: Bilateral Leaflet Modification Technique to Prevent Coronary Obstruction

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details

Marketplace

VahatiCor Begins United States SERRA-I Early Feasibility Study of A-Flux Reducer System for Microvascular Dysfunction

Explore the Site

Stay Connected